Routine hearing screening can identify patients who are motivated to seek out and adhere to treatment, but little information exists on the cost-effectiveness of hearing screening in a general population of older veterans. We compared the cost-effectiveness of three screening strategies (tone-emitti
We compared the cost-effectiveness of three screening strategies (tone-emitting otoscope, hearing handicap questionnaire, and both together) against no screening (control group) in 2,251 older veterans. The effectiveness measure for each group was the proportion of hearing aid use 1 year after screening.
2011-3-15 · screening strategies on utilization and costs of audiology care. We also examine the long-term cost-effectiveness of each of the SAI-WHAT study screening strategies. METHODS Screening Strategies The SAI-WHAT study was a four-group, randomized trial, including three screening strategies and one control group without screening. The three
2017-5-25 · Abstract — Routine hearing screening can identify patients who are motivated to seek out and adhere to treatment, but little information exists on the cost-effectiveness of hearing screening in a general population of older veterans.We compared the cost-effectiveness of three screening strategies (tone-emitting otoscope, hearing handicap questionnaire, and both together) against no screening
HCV screening and early treatment have the potential to improve average life-expectancy, but should focus on populations with elevated HCV prevalence to be cost-effective. Further research on the long-term health-economic impact of HCV screening when combined with appropriate monitoring strategies i
For a 60% coverage level of screening, cervical cancer reduction would be 49.2% for a 3-year periodicity. The reduction would be 40.3% and 33.1% for 5 and 10 years periodicity respectively. Considering cost-effectiveness, 10-year screening gave the lowest annual cost to avoid 1 cervical cancer case
598 Le Bras et al. Table 1 Description of 2016 data from French Biomedicine Agency (ABM) used to produce virtual cohort for cost-effectiveness analysis of five prenatal screening strategies* Data n or n (%) Source Women tested by maternal serum screening 652653 ABM (pers. comm., 2018) Risk from maternal serum screening ≥1/1000 89536 (13.
effectiveness of different strategies for screening and treating strongyloidiasis in people migrating from endemic countries to Europe. What are the new findings? Presumptively treating immunosuppressed migrants from endemic areas, without screening or testing, was a cost-saving strategy compared with the cur-rent base-case scenario.
2020-12-25 · ng sexually transmitted disease (STD) clinics. Incremental cost-effectiveness of 4 screening strategies were compared: 1) Endocervical DNA probe test (PACE2, Gen-Probe), 2) Endocervical AC2 (Aptima Combo 2, Gen-Probe), 3) Self-Obtained Vaginal AC2, and 4) Urine AC2. Sensitivities of the vaginal, urine, and cervical AC2 tests were derived from 324 women attending STD clinics. The
2018-3-24 · Cost-effectiveness analysis of programmatic screening strategies for LTBI in the EU/EEA TECHNICAL. REPORT . iv Table 5. Prices per item and the quantity provided under the different activities of tuberculosis control for the
2020-4-1 · Community-based screening and treatment of women aged 70–85 years at high fracture risk reduced fractures; moreover, the screening programme was cost-saving. The results support a case for a screening programme of fracture risk in older women in the UK. The SCOOP (screening for prevention of fractures in older women) randomized controlled trial investigated whether community-based screening
2009-2-5 · HCV screening and early treatment have the potential to improve average life-expectancy, but should focus on populations with elevated HCV prevalence to be cost-effective. Further research on the long-term health-economic impact of HCV screening when combined with appropriate monitoring strategies in different European health care systems is
2010-4-19 · WHO Principles of Screening 9The condition should be an important health problem. 9There should be a treatment for the condition. 9Facilities for diagnosis and treatment should be available. 9There should be a latent stage of the disease. 9There should be a test or examination for the condition. 9The test should be acceptable to the population. 9The natural history of the disease should be
2009-2-5 · The incremental cost-effectiveness ratios (ICER) of HCV screening vs. no screening varied over a wide range (18 300–1 151 000 €/QALY, if not dominated) depending on target population, study perspective, time horizon, discount rate and compared strategies including screening mode and antiviral treatment strategies.
2020-9-3 · conventional insulin therapy, screening and treatment strategies for microvascular complications, end-stage com-plications, and multifactorial interventions. The model comprises a series of inter-dependent semi-Markov sub-models that simulate mortality and diabetes-related complications (including angina, myocardial infarction,
estimates for targeted screening only, do not use sufficient patient-level data to estimate costs, or do not carry out a probabilistic analysis allowing for joint parameter uncertainty. In addition to cost-effectiveness estimates, a long-term screening model would also enable different fundamentals of the screening programme to be explored.
2020-1-30 · Grann VR, Patel PR, Jacobson JS, et al. Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers. Breast Cancer Res Treat. 2011;125:837–847.
2018-6-1 · systematic strategies consisted of opportunistic case-finding, where a respiratory screening ques-tionnaire was administered when eligible patients attended their primary care practice for consulta-tion, and an active approach, where patients were Key messages What is the key question? What is the long-term cost-effectiveness of
2017-6-26 · The NBCSP has potential to save 83 800 lives over the period 2015–40 if coverage rates can be increased to 60%. By contrast, the associated harms, although an important consideration, are at a smaller magnitude at the population level. The programme is highly cost-effective and within a decade of full roll-out, there will be reduced annual health systems expenditure on colorectal cancer
Objective To compare the long-term economic impact of melanoma prevention by sun protection, with the corresponding impact of early detection of melanoma to decrease melanoma deaths. Design Cost-effectiveness analysis using Markov cohort model. Data were primarily from two population-based randomised controlled trials, epidemiological and costing reports, and included flow-on effects for
2020-4-1 · Community-based screening and treatment of women aged 70–85 years at high fracture risk reduced fractures; moreover, the screening programme was cost-saving. The results support a case for a screening programme of fracture risk in older women in the UK. The SCOOP (screening for prevention of fractures in older women) randomized controlled trial investigated whether community-based screening
2010-4-19 · WHO Principles of Screening 9The condition should be an important health problem. 9There should be a treatment for the condition. 9Facilities for diagnosis and treatment should be available. 9There should be a latent stage of the disease. 9There should be a test or examination for the condition. 9The test should be acceptable to the population. 9The natural history of the disease should be
2018-6-1 · systematic strategies consisted of opportunistic case-finding, where a respiratory screening ques-tionnaire was administered when eligible patients attended their primary care practice for consulta-tion, and an active approach, where patients were Key messages What is the key question? What is the long-term cost-effectiveness of
2020-9-3 · conventional insulin therapy, screening and treatment strategies for microvascular complications, end-stage com-plications, and multifactorial interventions. The model comprises a series of inter-dependent semi-Markov sub-models that simulate mortality and diabetes-related complications (including angina, myocardial infarction,
2021-5-29 · Novel medical and surgical therapeutic strategies for management of HF with reduced ejection fraction (HFrEF) which have been demonstrated to improve survival and quality of life are labeled as cost-additive technological advances but very often lack cost-benefit analyses that will determine the incremental value to our patients and our health
2017-7-1 · Introduction. Colorectal cancer is the third most common cancer in Australia and the second most common cause of cancer death, with 14 962 new cases of bowel cancer diagnosed and 4149 bowel cancer deaths reported in 2013. 1 Most colorectal cancer cases (>90%) are diagnosed in individuals aged 50 years or older and the disease is more common in men than in women. 1 Due to the high
2020-12-22 · a stochastic individual-level microsimulation model, we simulated the lifetimes of 250 million pregnant women matched at baseline with the U.S. childbearing population on age, injection drug use behaviors, and hepatitis C virus (HCV) infection status. Modeled outcomes included hepatitis C diagnosis, treatment and cure, lifetime health care costs, quality-adjusted life years (QALY) and
2014-11-18 · The STrAtegies for RelaTives (START) psychological intervention for family carers has been the first to show both clinical effectiveness (reduced anxiety and depressive symptoms, reduced depression caseness, and improved quality of life) and cost-effectiveness for
Strategy III consisted of post-travel tuberculin skin testing alone, and isoniazid for all reactors. Strategy IV consisted of post-travel chest radiographic screening alone, and LTBI treatment for travellers with inactive TB. All strategies were compared with the status quo strategy of passive case detection.
Objective To compare the long-term economic impact of melanoma prevention by sun protection, with the corresponding impact of early detection of melanoma to decrease melanoma deaths. Design Cost-effectiveness analysis using Markov cohort model. Data were primarily from two population-based randomised controlled trials, epidemiological and costing reports, and included flow-on effects for